Mesoblast (MEOBF) EBT Growth (3y) (2017 - 2023)
Powered by 
Analysis
Mesoblast (MEOBF) EBT Growth (3y) (2017 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 58.60% |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 23.09% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 31.60% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 50.69% |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 34.70% |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 28.72% |
| Dec 31, 2022 | 10.51% |
| Sep 30, 2022 | -31.70% |
| Jun 30, 2022 | 106.17% |
| Mar 31, 2022 | 7.73% |
| Dec 31, 2021 | 1.78% |
| Sep 30, 2021 | -3.96% |
| Jun 30, 2021 | 116.19% |
| Mar 31, 2021 | -2.71% |
| Dec 31, 2020 | -38.52% |
| Sep 30, 2020 | -36.58% |
| Mar 31, 2020 | -58.72% |
| Dec 31, 2019 | -13.92% |
| Sep 30, 2019 | 31.33% |
| Jun 30, 2019 | 11.27% |
| Mar 31, 2019 | -21.21% |
| Dec 31, 2018 | -7.16% |
| Sep 30, 2018 | -28.31% |
| Jun 30, 2018 | 10.59% |
| Mar 31, 2018 | -11.92% |